[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00 -1.92% 153.00 155.00 157.00 156.00 156.00 156.00 47,727 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.2 -56.5 -72.8 - 274

Amryt Pharma Share Discussion Threads

Showing 4476 to 4491 of 6725 messages
Chat Pages: Latest  185  184  183  182  181  180  179  178  177  176  175  174  Older
DateSubjectAuthorDiscuss
15/4/2019
22:02
mdalos posted and then deleted it before I had time to read it. I wonder what he posted? Did anyone get a chance to read his post? Was it worth reading? LOL.
papillon
14/4/2019
20:34
I wonder what mdalos posted today? It will ever remain unknown because he has already deleted his post!! LOL. LOL. He's deleted it even quicker than normal. It's possible that no one got to read this post other than mdalos himself. Makes you wonder why he bothers to post in the first place. Perhaps he's closed his short and has turned bullish on AMYT and was predicting a 50p share price by the end of the week! LOL.
papillon
12/4/2019
22:21
mdalos1 12 Apr '19 - 20:42 - 4369 of 4369 0 0 0 £500 !!!! (@ 12.3p presumably) LOLs >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Yes, 12.30p, mdalos. Not the 2.30p I incorrectly posted in post 4368, but you never know perhaps I was predicting the future AMYT sp!! LOL. LOL.
papillon
12/4/2019
13:03
My mistake yesterday was correct! LOL. The results RNS will be Wednesday 17th
papillon
12/4/2019
08:23
Just looking on advfn AMYT quote and it showing 52 week range as ....12.32 to 1,232,500,000.00 .....dam if I'd have seen that price at the right time I would have sold one share and kept the rest !!! Lol
richpassi
11/4/2019
17:38
I briefly met with them at the UKIS show. Didn't go to presentation, however I did probe about the next Lox deal and where they were. I was a little disappointed that they didn't have anything in the immediate offing, however he was clear they would expect to have sign something up before the year-end. They did say that they have looked and done due diligence on a number of products, but they are being very cautious to make sure the sums add up, which is sensible. Hopefully Lox numbers are continuing to show good growth, as I like a biotech with revenues but I guess it's all on AP101, which they were keen to talk about.
waterloo01
11/4/2019
17:13
I agree, Tiananmen, AMYT could be a good gamble at this price. That's why I'm holding.
papillon
11/4/2019
16:54
We can all get it wrong at times and AIM stock adds to the uncertainty, I suspect Davy get it right more times than they get it wrong. FT also have a similar forecast at 72p. The main point is that circa 12p is very attractive at the minute
tiananmen
11/4/2019
16:05
Actually the 15th is Monday, not Wednesday, as I erroneously mentioned in my previous post. So Irish broker Davy gives a 93p share price target and a 75% chance of success with the AP101 trial. I remember Davy gave a price target of £23 to PVR when the share price was around £7 about 6 years ago. The PVR share price now? Just over 12p!!!!!! So I'd take any target for AMYT from Davy with a very large pinch of salt. Of course I hope they are correct! Fingers crossed.
papillon
11/4/2019
12:36
https://www.davyselect.ie/content/articles/weeklybook.pdfPage 58.Positive report and price target of 93p.I'll take my chances with those who know what they are talking about.
tiananmen
11/4/2019
12:14
mdalos1 11 Apr '19 - 09:19 - 4357 of 4358 0 0 0 Glutton for punishment wanting those "Results"... it isn't going to be good News. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Could be mdalos. Just a small gamble for me. Only got around £1k invested in AMYT. PS. Neither you, nor I, know whether the "Results" will contain good, or bad, news. Fingers crossed it's the former. PPS. If you are correct Tiananmen, that means next Wednesday.
papillon
11/4/2019
10:59
Apparently on the 15th of Apr
tiananmen
10/4/2019
22:14
Wonder when the 2018 Final Results RNS will be issued? Must surely be soon? Next week?
papillon
03/4/2019
23:55
mdalos1 3 Apr '19 - 19:44 - 4354 of 4354 0 0 0 Like a dead Cat it will "bounce" a bit. Only +ve news about Sales/revenue or the Gene Therapy venture or eventual AP101 Trial results will give this any sort of more permanent uplift to 17p and maybe back into the 20s. Sales/revenue is likely to simply remain "steady" The whole Gene Therapy venture is a medium to long-term exercise... really wouldn't expect anything too significant this year or next on that front. AP101... well... dragging it's heels now to this year-end and might still be a flop. This has got 8.5p written all over it to the Autumn without something +ve on any 1 of the 3 strands listed above. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> 8.5p? You could be right, mdalos. I hoping for a dead cat bounce up to the 200 day EMA (currently 15.8p and very slowly falling) following the 2018 Final Results RNS. I'm hoping that Lojuxta revenue is exceeding market expectations. I haven't got long to wait to find out my fate.
papillon
03/4/2019
14:56
Was always thus Pap, small pharma like the oilers are super high risk but I trade on narrow margins so my losses will be modest regardless.I do think the chart looks interesting from a contrary perspective... time will tell if we'll both be begging on the high street or ordering that second private jet, all imo dyor ofc.
rathean
03/4/2019
13:24
I had to see who this 'Bronxville' person is and found that he posts on the LSE chat board. By all accounts what he has been saying for months is correct.He has been warning about Amryt since the share price was trading in the 18-16 range. He has been saying that AP101 efficacy is only marginally better than the placebo.that Amryt have not signed a new drug since Lojuxta over 2 years ago.that there are too many executives on big salaries.and more recently that Amryt will have to do a raise more cash. (He had be positive on the gene therapy treatment but said he thought it was further along) I honestly do not have a clue why Papillion is disparaging him. Mind you. Bronxville is not a big fan of Papillion either.
chica1
Chat Pages: Latest  185  184  183  182  181  180  179  178  177  176  175  174  Older
ADVFN Advertorial
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210802 19:01:12